The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research. It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention,diagnosis and treatment. Homepage. How to publish in this journal. Contact. Join the conversation about this journal: Quartiles The.
Breast Cancer Research strongly encourages that all datasets on which the conclusions of the article rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files whenever possible. Please see Springer Nature’s.
Two such services are provided by our affiliates Nature Research Editing Service and American Journal Experts. BMC authors are entitled to a 10% discount on their first submission to either of these services. To claim 10% off English editing from Nature Research Editing Service, click here. To claim 10% off American Journal Experts, click here.
According to medical researchers and practitioners, treatment of lung cancer highly depends on the extent of the damage of the lungs by the cancer cells, the site of the primary tumour, the stage and the person’s general health.(Mazzini,2010). Before treatment is done to a lung cancer patient, he or she is provided with options on the side effects or discomfort that they a.
We are an electronic journal and there are no limits on the number or size of the papers we can publish. The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Cancer Management and Research has a quicker turnaround time than this. Generally peer review is.
Our journal submission experts are skilled in submitting papers to various international journals. After uploading your paper on Typeset, you would see a button to request a journal submission service for Archives in Cancer Research. Each submission service is completed within 4 - 5 working days.
At BMC Cancer we are seeking submissions of study protocols of trials reporting on outcomes of therapeutics (immunotherapy, chemotherapy or combination of both), radiotherapy, cancer surgery or a combination of these. For radiotherapy-related studies we strongly encourage submissions of studies that report on outcomes of stereotactic radiotherapy (SRT, SABR or SBRT). Study protocols reporting.
Clinical Cancer Research prioritizes the mechanistic evaluation of novel compounds and rational combinations for cancer therapy. Due to the overwhelming number of submissions in this Section of the Journal, guidelines are listed below to assist authors in their preparation of the manuscript. Flexibility will be maintained in the review process in regard to the availability of human samples.